These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37483001)

  • 41. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
    Apaydin H; Ahlskog JE; Parisi JE; Boeve BF; Dickson DW
    Arch Neurol; 2002 Jan; 59(1):102-12. PubMed ID: 11790237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial.
    Querfurth HW; Allam GJ; Geffroy MA; Schiff HB; Kaplan RF
    Dement Geriatr Cogn Disord; 2000; 11(6):314-21. PubMed ID: 11044776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson's disease.
    Hattori N; Takeda A; Takeda S; Nishimura A; Nakaya R; Mochizuki H; Nagai M; Takahashi R
    J Neural Transm (Vienna); 2019 Mar; 126(3):289-297. PubMed ID: 30635744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.
    Fujishiro H; Kasanuki K; Nakamura S
    Psychogeriatrics; 2013 Dec; 13(4):250-3. PubMed ID: 24289466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic trials in dementia with Lewy bodies: a systematic review of the literature].
    Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2021 Sep; 19(3):289-304. PubMed ID: 34609295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB).
    Lang FM; Kwon DY; Aarsland D; Boeve B; Tousi B; Harnett M; Mo Y; Noel Sabbagh M
    Alzheimers Dement (N Y); 2021; 7(1):e12171. PubMed ID: 34189249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
    Mori S; Mori E; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
    Hatano T; Kano O; Sengoku R; Yoritaka A; Suzuki K; Nishikawa N; Mukai Y; Nomura K; Yoshida N; Seki M; Matsukawa MK; Terashi H; Kimura K; Tashiro J; Hirano S; Murakami H; Joki H; Uchiyama T; Shimura H; Ogaki K; Fukae J; Tsuboi Y; Takahashi K; Yamamoto T; Yanagisawa N; Nagayama H
    BMC Neurol; 2022 Mar; 22(1):71. PubMed ID: 35241003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease.
    Suzuki K; Fujita H; Matsubara T; Haruyama Y; Kadowaki T; Funakoshi K; Watanabe Y; Hirata K
    Brain Behav; 2021 Mar; 11(3):e02026. PubMed ID: 33399276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.
    Liu S; Liu J; Wang XD; Shi Z; Zhou Y; Li J; Yu T; Ji Y
    Int Psychogeriatr; 2018 Aug; 30(8):1131-1138. PubMed ID: 29223171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zonisamide: in Parkinson's disease.
    Yang LP; Perry CM
    CNS Drugs; 2009 Aug; 23(8):703-11. PubMed ID: 19594199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
    Manabe Y; Odawara T; Konishi O
    Psychogeriatrics; 2019 Jul; 19(4):345-354. PubMed ID: 30784148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
    Goldman JG; Goetz CG; Brandabur M; Sanfilippo M; Stebbins GT
    Mov Disord; 2008 Nov; 23(15):2248-50. PubMed ID: 18823039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caregiver self-efficacy and associated factors among caregivers of patients with dementia with Lewy bodies and caregivers of patients with Alzheimer's disease.
    Sato H; Nakaaki S; Sato J; Shikimoto R; Furukawa TA; Mimura M; Akechi T
    Psychogeriatrics; 2021 Sep; 21(5):783-794. PubMed ID: 34216184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia.
    Bonelli SB; Ransmayr G; Steffelbauer M; Lukas T; Lampl C; Deibl M
    Neurology; 2004 Jul; 63(2):376-8. PubMed ID: 15277644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.